Spyre Therapeutics (SYRE) Preferred Shares Issued (2015 - 2024)
Spyre Therapeutics posted quarterly Preferred Shares Issued of -$169.2 million for Q2 2024, down 180.57% year-on-year from $210.0 million in Q3 2023, and down 200.0% on a QoQ basis from $169.2 million in Q1 2024.
Spyre Therapeutics (SYRE) has 3 years of Preferred Shares Issued data on file, last reported at -$169.2 million in Q2 2024.
- For the quarter ending Q2 2024, Preferred Shares Issued fell 180.57% year-over-year to -$169.2 million; the trailing twelve-month figure through Jun 2024 stood at -$12.6 million (down 106.02% YoY), and the FY2023 full-year result was $197.4 million, changed N/A from the prior year.
- Preferred Shares Issued for Q2 2024 stood at -$169.2 million, down from $169.2 million in the prior quarter.
- Across five years, Preferred Shares Issued topped out at $210.0 million in Q2 2023 and bottomed at -$169.2 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Spyre Therapeutics | 5.55 Bn | 5.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -169.21 Mn |
| Jun 30, 2024 | -169.21 Mn |
| Mar 31, 2024 | 169.21 Mn |
| Mar 31, 2024 | 169.21 Mn |
| Sep 30, 2023 | -12.64 Mn |
| Sep 30, 2023 | -12.64 Mn |
| Jun 30, 2023 | 210.00 Mn |
| Jun 30, 2023 | 210.00 Mn |
| Sep 30, 2015 | -5,000.00 |
| Sep 30, 2015 | -5,000.00 |
| Jun 30, 2015 | 6,000.00 |
| Jun 30, 2015 | 6,000.00 |
| Mar 31, 2015 | 43.68 Mn |
| Mar 31, 2015 | 43.68 Mn |